LOCAL BOUNTI CORP (LOCL)

US53960E2054 - Common Stock

2.12  +0.09 (+4.43%)

After market: 2.19 +0.07 (+3.3%)

Fundamental Rating

2

Overall LOCL gets a fundamental rating of 2 out of 10. We evaluated LOCL against 91 industry peers in the Food Products industry. Both the profitability and financial health of LOCL have multiple concerns. LOCL is valued quite expensive, but it does show an excellent growth.



0

1. Profitability

1.1 Basic Checks

LOCL had negative earnings in the past year.
In the past year LOCL has reported a negative cash flow from operations.
In the past 5 years LOCL always reported negative net income.
In the past 5 years LOCL always reported negative operating cash flow.

1.2 Ratios

LOCL has a worse Return On Assets (-34.63%) than 81.32% of its industry peers.
Industry RankSector Rank
ROA -34.63%
ROE N/A
ROIC N/A
ROA(3y)-37.11%
ROA(5y)-52.31%
ROE(3y)-319.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LOCL has a worse Gross Margin (12.11%) than 63.74% of its industry peers.
LOCL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

LOCL does not have a ROIC to compare to the WACC, probably because it is not profitable.
LOCL has more shares outstanding than it did 1 year ago.
The debt/assets ratio for LOCL is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -1.74, we must say that LOCL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.74, LOCL is not doing good in the industry: 79.12% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.74
ROIC/WACCN/A
WACC2.47%

2.3 Liquidity

LOCL has a Current Ratio of 0.33. This is a bad value and indicates that LOCL is not financially healthy enough and could expect problems in meeting its short term obligations.
LOCL has a worse Current ratio (0.33) than 95.60% of its industry peers.
LOCL has a Quick Ratio of 0.33. This is a bad value and indicates that LOCL is not financially healthy enough and could expect problems in meeting its short term obligations.
LOCL has a Quick ratio of 0.20. This is amonst the worse of the industry: LOCL underperforms 95.60% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.2

7

3. Growth

3.1 Past

LOCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.59%.
LOCL shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.82%.
LOCL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 600.99% yearly.
EPS 1Y (TTM)-59.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.79%
Revenue 1Y (TTM)27.82%
Revenue growth 3Y600.99%
Revenue growth 5YN/A
Sales Q2Q%50.4%

3.2 Future

The Earnings Per Share is expected to grow by 20.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 50.30% on average over the next years. This is a very strong growth
EPS Next Y8.89%
EPS Next 2Y26.24%
EPS Next 3Y20.56%
EPS Next 5YN/A
Revenue Next Year32.68%
Revenue Next 2Y65.9%
Revenue Next 3Y64.6%
Revenue Next 5Y50.3%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

LOCL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LOCL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

LOCL's earnings are expected to grow with 20.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.24%
EPS Next 3Y20.56%

0

5. Dividend

5.1 Amount

LOCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LOCAL BOUNTI CORP

NYSE:LOCL (12/23/2024, 8:17:06 PM)

After market: 2.19 +0.07 (+3.3%)

2.12

+0.09 (+4.43%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners11.08%
Inst Owner Change0.27%
Ins Owners16.27%
Ins Owner Change1.86%
Market Cap18.36M
Analysts85
Price Target8.16 (284.91%)
Short Float %1.69%
Short Ratio3.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-54.98%
Min EPS beat(2)-83.19%
Max EPS beat(2)-26.77%
EPS beat(4)0
Avg EPS beat(4)-92.72%
Min EPS beat(4)-228.83%
Max EPS beat(4)-26.77%
EPS beat(8)2
Avg EPS beat(8)-41.48%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.11%
Min Revenue beat(2)-21.25%
Max Revenue beat(2)-16.97%
Revenue beat(4)0
Avg Revenue beat(4)-15.75%
Min Revenue beat(4)-22.63%
Max Revenue beat(4)-2.16%
Revenue beat(8)1
Avg Revenue beat(8)-11.95%
Revenue beat(12)3
Avg Revenue beat(12)-7.99%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.65%
EPS NY rev (1m)-22.86%
EPS NY rev (3m)-22.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-47.36%
Revenue NY rev (1m)-25.94%
Revenue NY rev (3m)-25.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-17.97
EYN/A
EPS(NY)-6.28
Fwd EYN/A
FCF(TTM)-17.68
FCFYN/A
OCF(TTM)-4.09
OCFYN/A
SpS4.03
BVpS-7.58
TBVpS-12.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.63%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.11%
FCFM N/A
ROA(3y)-37.11%
ROA(5y)-52.31%
ROE(3y)-319.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 738.24%
Cap/Sales 336.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.2
Altman-Z -1.74
F-Score3
WACC2.47%
ROIC/WACCN/A
Cap/Depr(3y)2127.81%
Cap/Depr(5y)N/A
Cap/Sales(3y)1881.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.79%
EPS Next Y8.89%
EPS Next 2Y26.24%
EPS Next 3Y20.56%
EPS Next 5YN/A
Revenue 1Y (TTM)27.82%
Revenue growth 3Y600.99%
Revenue growth 5YN/A
Sales Q2Q%50.4%
Revenue Next Year32.68%
Revenue Next 2Y65.9%
Revenue Next 3Y64.6%
Revenue Next 5Y50.3%
EBIT growth 1Y21.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year61.23%
EBIT Next 3Y32.84%
EBIT Next 5Y23.97%
FCF growth 1Y18.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.98%
OCF growth 3YN/A
OCF growth 5YN/A